tiprankstipranks

Douglas Losordo Insider Profile

4 Followers
Douglas Losordo, EVP, Global Head of Research and Development and C at Lisata Therapeutics, holds 5.00K shares in Longeveron (Ticker: LGVN), holds 130.41K shares in Lisata Therapeutics (Ticker: LSTA), holds ― shares in Cadrenal Therapeutics, Inc. (Ticker: CVKD).
tipranks
Douglas Losordo

Douglas Losordo
Lisata Therapeutics (LSTA)
EVP, Global Head of Research and Development and C

Not Ranked
Douglas Losordo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$378K
98.23%
1.77%
0.00%
A breakdown of Douglas Losordo's holdings

Insider Roles

Lisata Therapeutics
(LSTA)
EVP, Global Head of Research and Development and C
Longeveron
(LGVN)
Director
Cadrenal Therapeutics, Inc.
(CVKD)
Chief Medical Officer
Roles that Douglas Losordo holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Douglas Losordo

Douglas Losordo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lisata Therapeutics
Jan 15, 2020
EVP, Global Head of Research and Development and C
Uninformative Buy
$370.87K
Longeveron
Feb 17, 2021
Director
Uninformative Buy
$6.70K
Cadrenal Therapeutics, Inc.
Chief Medical Officer
List of latest transactions for each holding click on a transaction to see Douglas Losordo's performance on stock

Douglas Losordo insider profile FAQ

What is the percentage of profitable transactions made by Douglas Losordo?
The percentage of profitable transactions made by Douglas Losordo is ―.
    What is the average return per transaction made by Douglas Losordo?
    The average return per transaction made by Douglas Losordo is ―.
      What stocks does Douglas Losordo hold?
      Douglas Losordo holds: LSTA, LGVN, CVKD stocks.
        What was Douglas Losordo’s latest transaction?
        Douglas Losordo latest transaction was an Uninformative Buy of ―.
          What was Douglas Losordo's most profitable transaction?
          Douglas Losordo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Douglas Losordo's role in Lisata Therapeutics?
            Douglas Losordo's role in Lisata Therapeutics is EVP, Global Head of Research and Development and C.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.